Colorectal Cancer Survivor Symptom Management (CRCaSSM)

Akdeniz University

Status: Completed

Conditions: Survivorship; Colorectal Cancer

Treatments: Other: CRCaSSM

Study type: Interventional

Funder types: Other

Identifiers

NCT05876338

KAEK-686

Details and patient eligibility

About

Objective: The aim of this study was to examine the effects of nursing interventions based on the symptom management model on symptom management, fear of recurrence, and quality of life in colorectal cancer survivors.

Method: The research was planned as a randomized controlled trial. The research is planned to be carried out at Akdeniz University Hospital. It is planned to be done with 52 patients, 26 experimental and 26 control groups. The intervention group will receive face-to-face training and telephone counseling based on the symptom management model. After the training, it is planned to provide telephone counseling for a total of 6 times, once every 2 weeks for 3 months. Participant Information Form, Memorial Symptom Assessment Scale, Fear of Cancer Recurrence Inventory and European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire Scale Scale will be used to collect data.

Enrollment: 40 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

1. Be 18 years or older
2. Being able to read and write
3. Being oriented to place, time, person
4. Not having a hearing problem
5. Not having a speech problem
6. Being able to use the phone
7. Primary medical diagnosis is colorectal cancer
8. Patients who have completed primary treatment for colorectal cancer and are followed up
9. Not to relapse
10. Being in remission
11. Having a Karnofsky Performance Scale of 70% and above and being followed on an outpatient basis

Exclusion criteria

1.Patients with cognitive problems

Exclusion Criteria from the Sample During the Research:

1. Patient's wish to leave the study
2. Continuing the outpatient follow-up of the patient in the medical oncology outpatient clinic of another institution

Trial design

Primary purpose: Supportive Care

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

40 participants in 2 patient groups

CRCaSSM

Experimental group

Description:

CRCaSSM

Treatment:

Other: CRCaSSM

Control

No Intervention group